Display options
Cite
Ganguly Bhattacharjee K, Bhattacharyya M, Halder UC, et al. The Role of Neutrophil Estrogen Receptor Status on Maspin Synthesis via Nitric Oxide Production in Human Breast Cancer. J Breast Cancer. 2012;15(2):181-8doi: 10.4048/jbc.2012.15.2.181.
Ganguly Bhattacharjee, K., Bhattacharyya, M., Halder, U. C., Jana, P., & Sinha, A. K. (2012). The Role of Neutrophil Estrogen Receptor Status on Maspin Synthesis via Nitric Oxide Production in Human Breast Cancer. Journal of breast cancer, 15(2), 181-8. https://doi.org/10.4048/jbc.2012.15.2.181
Ganguly Bhattacharjee, Karabi, et al. "The Role of Neutrophil Estrogen Receptor Status on Maspin Synthesis via Nitric Oxide Production in Human Breast Cancer." Journal of breast cancer vol. 15,2 (2012): 181-8. doi: https://doi.org/10.4048/jbc.2012.15.2.181
Ganguly Bhattacharjee K, Bhattacharyya M, Halder UC, Jana P, Sinha AK. The Role of Neutrophil Estrogen Receptor Status on Maspin Synthesis via Nitric Oxide Production in Human Breast Cancer. J Breast Cancer. 2012 Jun;15(2):181-8. doi: 10.4048/jbc.2012.15.2.181. Epub 2012 Jun 28. PMID: 22807935; PMCID: PMC3395741.
Copy Download .nbib Format: NLM
Share it on

J Breast Cancer. 2012 Jun;15(2):181-8. doi: 10.4048/jbc.2012.15.2.181. Epub 2012 Jun 28.

The Role of Neutrophil Estrogen Receptor Status on Maspin Synthesis via Nitric Oxide Production in Human Breast Cancer.

Journal of breast cancer

Karabi Ganguly Bhattacharjee, Mau Bhattacharyya, Umesh Chandra Halder, Pradipta Jana, Asru K Sinha

Affiliations

  1. Sinha Institute of Medical Science & Technology, Garia, India.

PMID: 22807935 PMCID: PMC3395741 DOI: 10.4048/jbc.2012.15.2.181

Abstract

PURPOSE: Estrogen, through its binding to nuclear estrogen receptor (ER), has been implicated in the development of human breast cancer. The presence or absence of ER in breast lesions has been used to classify breast cancer into ER+ or ER- type. Maspin, an anti-breast cancer protein produced in normal mammary cells, has also been reported to control the condition. Studies have been conducted to determine the role of ER+ and ER- status in neutrophils in the synthesis of maspin in human breast cancer.

METHODS: Maspin presence was determined by enzyme linked immunosorbent assay, while nitric oxide (NO) level was determined using the methemoglobin method.

RESULTS: Scatchard plots of the equilibrium binding of estrogen demonstrated the presence of 4.18×10(7) receptors per normal neutrophil and 2.46×10(7) receptors per ER+ neutrophil with a similar dissociation constant (0.926 nM). The ER- type showed nonspecific estrogen binding only. At 0.6 nM estrogen, NO synthesis was maximally increased to 1.829 and 0.887 µM NO/10(9) cells at 4 hours in normal and ER+ neutrophils respectively, with synthesis of 2.383 and 1.422 nM maspin in normal and ER+ neutrophils respectively. Estrogen failed to produce these effects in ER- neutrophils.

CONCLUSION: ER status in neutrophils determined maspin synthesis in breast cancer through the stimulation of NO synthesis. Neutrophils with ER- status which do not produce any maspin when treated with estrogen, might imply a worse prognostic outcome in ER- breast cancer due to the lack of anti-breast cancer protein synthesis.

Keywords: Breast neoplasms; Estrogen receptors; Maspin; Neutrophils; Nitric oxide

References

  1. Cancer Lett. 2001 Sep 28;171(1):103-10 - PubMed
  2. J Immunol. 1972 Jul;109(1):129-35 - PubMed
  3. Science. 1994 Jan 28;263(5146):526-9 - PubMed
  4. Breast Cancer Res Treat. 1986;8(3):179-88 - PubMed
  5. Blood. 1976 Jul;48(1):149-61 - PubMed
  6. Hum Reprod Update. 2000 May-Jun;6(3):225-36 - PubMed
  7. J Cancer Res Clin Oncol. 2006 Jun;132(6):389-98 - PubMed
  8. J Clin Microbiol. 2000 Dec;38(12):4326-31 - PubMed
  9. J Biol Chem. 1999 Oct 15;274(42):29628-32 - PubMed
  10. J Anal Toxicol. 1982 May-Jun;6(3):148-52 - PubMed
  11. Endocr Relat Cancer. 2003 Jun;10(2):261-6 - PubMed
  12. BMC Cancer. 2008 Nov 07;8:323 - PubMed
  13. Life Sci. 2000 Jul 7;67(7):743-57 - PubMed
  14. Int J Fertil Womens Med. 1998 Nov-Dec;43(6):278-85 - PubMed
  15. Folia Biol (Praha). 1980;26(2):81-93 - PubMed
  16. J Biol Chem. 1990 Mar 25;265(9):4976-81 - PubMed
  17. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8664-7 - PubMed
  18. Eur J Biochem. 1979 Sep;99(2):247-52 - PubMed
  19. Oncology. 2010;79(1-2):55-61 - PubMed

Publication Types